Raymond James & Associates’s iCAD Inc ICAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,350
Closed -$40.8K 3880
2023
Q3
$40.8K Sell
19,350
-196
-1% -$467 ﹤0.01% 3690
2023
Q2
$31.9K Hold
19,546
﹤0.01% 3742
2023
Q1
$24.2K Buy
19,546
+1,000
+5% +$2.08K ﹤0.01% 3782
2022
Q4
$33.9K Sell
18,546
-2,104
-10% -$3.92K ﹤0.01% 3749
2022
Q3
$43K Hold
20,650
﹤0.01% 3722
2022
Q2
$83K Sell
20,650
-1,100
-5% -$4.19K ﹤0.01% 3716
2022
Q1
$97K Buy
21,750
+8,331
+62% +$41.9K ﹤0.01% 3824
2021
Q4
$97K Sell
13,419
-1,300
-9% -$11.6K ﹤0.01% 3865
2021
Q3
$158K Buy
+14,719
New +$192K ﹤0.01% 3726

Other funds holding ICAD

Raymond James & Associates's ICAD Position: Q4 2023 in Review

Raymond James & Associates sold out of iCAD Inc (ICAD) in Q4 2023, closing a stake of 19,350 shares — an estimated $40.8K sold.

Raymond James & Associates first reported a position in ICAD in Q3 2021 and held it in 9 quarters. The position peaked at $158K in Q3 2021. 52 funds tracked by Wall St. Rank hold ICAD as of Q4 2023.

  • Raymond James & Associates reported no remaining iCAD Inc position as of Q4 2023 after selling out during the quarter.
  • Raymond James & Associates sold 19,350 iCAD Inc shares in Q4 2023, an estimated $40.8K.
  • Raymond James & Associates first reported a position in iCAD Inc in Q3 2021 and held it in 9 quarters.
  • Raymond James & Associates's iCAD Inc position peaked at $158K in Q3 2021.
  • 52 funds tracked by Wall St. Rank held iCAD Inc as of Q4 2023.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.